The National Institutes of Health has launched two of three adaptive clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100 sites around the world, including University of Florida … Continue reading UF Health, OneFlorida Consortium to Evaluate Blood Thinners As COVID-19 Treatment